Kidney Transplant Rejection
📧 Sign up to get email alerts when something new happens for Kidney Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-01-21FDA Approved: CYCLOSPORINE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith's original ANDA for generic cyclosporine.
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Molecular HistoMx Assessment for Kidney Transplant Rejection and Management
This clinical trial evaluating Molecular HistoMx for detecting and managing kidney transplant rejection has completed.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS
This clinical trial update reports transcriptional profiling of peripheral blood cells in a patient with kidney and lung graft rejection and…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation [Phase 3]
A Phase 3 trial evaluating rituximab for progression of humoral acute rejection after kidney transplantation has completed.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Blood Biomarkers in Pediatric Kidney Transplant Recipients
This clinical trial investigates blood biomarkers in pediatric kidney transplant recipients to monitor rejection. The study is currently act…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients [Phase 2]
Clinical trial update indicates Tegoprubart is being studied in Phase 2 for long-term safety and efficacy in kidney transplant recipients, w…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Platelet Aggregation in the Diagnosis of Acute Graft Rejection
A recruiting clinical trial evaluating whether platelet aggregation can aid in diagnosing acute kidney transplant rejection.
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)
Long-term follow-up data on the investigational TX200-TR101 therapy (STEADFAST Long Term) evaluating outcomes in kidney transplant rejection…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants [Phase 1]
Phase 1 clinical trial evaluating delayed immunological tolerance in well-functioning, HLA-matched kidney transplant recipients; currently r…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection
This document provides an update on Verici Dx’s clinical trial validating genomic immune-phenotyping profiles to predict the risk of kidney …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring
This study is validating donor-derived cell-free DNA as a noninvasive biomarker to monitor kidney transplant rejection and is currently recr…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: PIONEER Trial (Post-Transplant Application of TruGraf and TRAC Molecular Panel in Renal Transplant Recipients)
This document provides an update on the PIONEER trial evaluating the post-transplant use of TruGraf and TRAC Molecular Panel in renal transp…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation [Phase 2]
Phase 2 clinical trial update for Belumosudil to address interstitial fibrosis and tubular atrophy following kidney transplantation, in the …
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR [Phase 4]
Phase 4 trial evaluating a simplified, low-dose tacrolimus (Envarsus XR) immunosuppressive protocol in kidney transplantation; the study sta…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation [Phase 2]
Phase 2 trial results for Tegoprubart in patients undergoing kidney transplantation, reporting safety and efficacy for preventing or treatin…
-
FDA approval · 2025-10-17FDA Approved: TACROLIMUS — Supplemental Application (NORTHSTAR RX LLC)
The FDA approved a supplemental application for tacrolimus (generic) submitted by NORTHSTAR RX LLC.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients [Phase 1]
A Phase 1 clinical trial evaluating adipose-derived mesenchymal stem cells to treat rejection in kidney transplant recipients is currently r…
-
FDA approval · 2025-09-26FDA Approved: TACROLIMUS — Supplemental Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma Inc.'s supplemental application for tacrolimus, updating labeling to support its use in preventing organ transpla…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: To Explore the Application Value of Magnetic Resonance Imaging in Noninvasive Quantitative Evaluation of Graft Function and Systemic Metabolism After Renal Transplantation
A clinical trial update investigating the use of magnetic resonance imaging to noninvasively quantify graft function and systemic metabolism…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection
This study is evaluating whether donor-derived cell-free DNA (Dd-cfDNA) and regulatory T cells (Treg) can predict acute kidney transplant re…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Molecular Transcriptomics in Diagnosing Pediatric Kidney Transplant Rejection: the PANDA-Kids-ATLAS Study
This trial investigates using molecular transcriptomics to diagnose kidney transplant rejection in children. The PANDA-Kids-ATLAS study is c…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Daratumumab for Late Antibody-Mediated Rejection [NA]
A clinical trial is evaluating daratumumab for late antibody-mediated rejection in kidney transplant recipients, and the study is currently …
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Australian Genomics Of Chronic Allograft Dysfunction Study
The Australian Genomics Of Chronic Allograft Dysfunction study is currently recruiting, sponsored by Western Sydney Local Health District, f…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study using CRISPR-edited HLA donor kidneys to reduce transplant rejection risk, with recru…
-
FDA approval · 2025-06-27FDA Approved: MYHIBBIN — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for MYHIBBIN (mycophenolate mofetil) submitted by Azurity Pharmaceuticals, Inc. The supplement perta…